Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject<sup>TM</sup> by peripheral health care providers at home births: design of a community-based cluster-randomized trial
<p>Abstract</p> <p>Background</p> <p>Hemorrhage is the leading direct cause of maternal death globally. While oxytocin is the drug of choice for postpartum hemorrhage prevention, its use has generally been limited to health facilities. This trial assesses the effectiven...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2393/12/42 |